Management

Zydus Cadila files anti-diabetic drug application with DCGI

Healthcare services provider Zydus Cadila has filed an application before the Drugs Controller General of India (DCGI) for its anti-diabetic drug. The company has filed an investigational new drug (IND) application before the DCGI for its ZYD1 drug, used in the treatment of diabetes, Cadila Healthcare, the flagship company of Zydus Cadila group, said in a filing to the Bombay Stock Exchange. The global anti-diabetic market is estimated at Rs 24 billion dollars in 2008.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
TMB eyes Rs 20,000 cr business
Tuticorin-based Tamilnad Mercantile Bank (TMB) has set a target of Rs 20, 000 crore business by March 2010 from the present Rs 16,000 crore.
Popular Articles
payday loans online

PGP Educational lines up Rs 100 crore investment
City-based PGP Educational & Welfare Society, which runs engineering and arts colleges, is now planning to become an integrated one stop point by including medical education. The trust had already applied for a university status.

Japan asks India to sign CTBT
PM puts onus on US, China.

© Copyright 2009